BeautyHealth $18 Million Securities Settlement, Who Can Claim, Deadlines and Estimated Payout for SKIN Investors

Investors who purchased or acquired The Beauty Health Company (“BeautyHealth”) common stock or call options, or sold or otherwise disposed of put options, between May 10, 2022 and November 13, 2023, inclusive, may be eligible for a share of an $18 million cash settlement. The company, now named SkinHealth Systems Inc., traded on Nasdaq under the ticker SKIN.

The deadline to file a Proof of Claim and Release is January 19, 2027. Requests to opt out or object are due earlier, by November 24, 2026. The final approval hearing is December 9, 2026, at 1:30 p.m. Pacific Time.

The settlement resolves Alghazwi v. The Beauty Health Company, Andrew Stanleick and Liyuan Woo, Case No. 2:23-cv-09733-SPG-MAA, pending before U.S. District Judge Sherilyn Peace Garnett in the Central District of California. The company and the individual defendants deny any wrongdoing, and the settlement is not an admission of liability.

The estimated recovery is roughly $0.35 per allegedly damaged common share, but that is an estimate, not a guaranteed payment. Your actual amount depends on your transactions, the court-approved plan of allocation and the number of valid claims filed.

Official settlement website: BeautyHealthSecuritiesLitigation.com

BeautyHealth Securities Settlement: Quick Facts

Detail	Information
Settlement amount	$18,000,000 in cash
Who pays	SkinHealth Systems pays $3 million; insurers cover the remaining $15 million
Estimated net fund	At least $12,015,000 after the maximum requested fees and expenses, per the settlement notice figures
Case	Alghazwi v. The Beauty Health Company, et al., No. 2:23-cv-09733-SPG-MAA (C.D. Cal.)
Defendants	The Beauty Health Company; Andrew Stanleick; Liyuan Woo
Class period	May 10, 2022 through November 13, 2023, inclusive
Securities covered	Common stock and call options (purchased or acquired); put options (sold or disposed of)
Estimated recovery	About $0.35 per allegedly damaged common share (estimate only)
Opt-out and objection deadline	November 24, 2026 (must be received)
Final approval hearing	December 9, 2026, 1:30 p.m. PT, Los Angeles
Claim deadline	January 19, 2027
Administrator	Stretto, 410 Exchange, Suite 100, Irvine, CA 92602
Contact	[email protected]

Who Is Eligible for the BeautyHealth Securities Settlement?

You may be a Settlement Class Member if, during May 10, 2022 through November 13, 2023, inclusive, you:

• purchased or otherwise acquired BeautyHealth common stock or call options, or
• sold or otherwise disposed of BeautyHealth put options,

and were damaged as a result. The class was preliminarily certified for settlement purposes only. The court decides final certification at the December 9 hearing.

Owning SKIN stock at some point does not by itself qualify you. Purchases made before May 10, 2022 or after November 13, 2023 fall outside the class period. Defendants and certain related persons and entities are excluded, and the official notice lists the full exclusions.

Options claims work differently from stock claims. Keep the contract type, strike price, expiration date and trade dates, and do not apply the per-share estimate to option contracts.

How Much Could You Receive From the BeautyHealth Settlement?

The $18 million is a gross figure. Lead counsel may request attorneys’ fees of up to 30% of the settlement, or $5,400,000. The court decides whether to approve the fees, the expenses and any service awards.

Deduction (maximum requested or estimated)	Amount
Attorneys’ fees	Up to $5,400,000
Litigation expenses	Up to $325,000
Notice and administration	Up to $250,000
Service awards for two lead plaintiffs	Up to $5,000 each
Estimated net fund	At least $12,015,000

Each claimant’s payment is calculated under the plan of allocation, which measures a recognized loss on each qualifying transaction, so two investors with the same number of shares can receive different amounts. Settlements of this kind often pay a small fraction of investor losses. Bloomberg Law reported that the plaintiffs told the court the settlement equals about 14% of their estimated $125 million in maximum damages.

For comparison with other cases covered on AllAboutLawyer, the DiDi Global $740 Million Securities Class Action Settlement, Investors Can Claim Up To $1.84 Per Share, Deadline April 6, 2026 and the Catalent $78M Securities Class Action Lawsuit Settlement, Claim Deadline May 26, 2026—Eligible Investors Could Receive Up to $0.44 Per Share each have their own allocation plans and eligibility rules. Eligibility in one settlement says nothing about another.

What Did the BeautyHealth Securities Lawsuit Allege?

The investors alleged that BeautyHealth and certain executives made materially false or misleading statements, or omitted material facts, about the company’s Syndeo 1.0 and 2.0 devices, the flagship machines of its Hydrafacial brand. According to the complaint as described by plaintiffs’ counsel, the devices had issues causing “frequent treatment interruptions.” The company allegedly incurred significant costs to develop enhancements, providers kept experiencing problems, and the company would stop marketing the earlier devices and take significant inventory write-downs, hurting profitability.

Two dates anchor the allegations:

• August 9, 2023: BeautyHealth disclosed that its second-quarter gross margin was hurt by a shift toward lower-margin refurbished devices while U.S. providers awaited Syndeo enhancements. The complaint treats this as an earlier partial disclosure.
• November 13, 2023: BeautyHealth reported third-quarter results “overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges” tied to device upgrades. It cut its 2023 net sales guidance, suspended its long-term 2025 outlook and announced that CEO Andrew Stanleick would depart effective November 19, 2023. The complaint alleges the share price fell by more than 64% on the news.

The defendants deny these allegations, and no court has found that they violated the securities laws.

Which Laws Apply in the BeautyHealth Securities Class Action?

The claims were brought under the Securities Exchange Act of 1934:

• Section 10(b) (15 U.S.C. § 78j(b)) and SEC Rule 10b-5 (17 C.F.R. § 240.10b-5) prohibit deceptive devices and material misstatements or omissions in connection with the purchase or sale of securities. A plaintiff generally must show a material misrepresentation or omission, the required state of mind, reliance, economic loss and loss causation.
• Section 20(a) (15 U.S.C. § 78t(a)) imposes control-person liability on certain individuals who control a party liable under the Act. Here it was asserted against the individual defendants.

The court denied the defendants’ motion to dismiss, and the parties later settled.

How to File a BeautyHealth Securities Settlement Claim

1. Gather your records. Collect brokerage statements and trade confirmations for BeautyHealth transactions from May 10, 2022 through November 13, 2023. If you changed brokers, ask your broker for historical statements.
2. Get the Proof of Claim and Release form from the official settlement website.
3. Report your transactions accurately and attach the documentation the form requests. Do not estimate prices or report shares you cannot support.
4. Submit by January 19, 2027. File electronically on the website or mail the form, postmarked by that date, to: BeautyHealth Securities Settlement, c/o Stretto, 410 Exchange, Suite 100, Irvine, CA 92602.
5. Keep copies of the form and any confirmation.

You do not need a lawyer to file. Filing does not guarantee payment, and late claims may be rejected.

BeautyHealth Settlement Deadlines: Opt-Out, Objection, Hearing and Claim

Date	Event
November 24, 2026	Exclusion (opt-out) requests and objections must be received or filed
December 9, 2026, 1:30 p.m. PT	Final approval hearing, U.S. District Court, Central District of California, Los Angeles
January 19, 2027	Proof of Claim deadline

Opting out. If you exclude yourself, you receive no payment and keep the right to sue on your own, subject to the law and any defenses. Your written request must follow the notice’s instructions and be received by November 24, 2026, since a postmark alone does not meet the deadline.

Objecting. You may object to the settlement, the plan of allocation or the requested fees by following the notice’s procedure by the same date. An objection is not an opt-out, so if you still want money, file a claim as well.

Doing nothing. If the court grants final approval and you take no action, you are generally bound by the settlement and the release of claims, but you will not be paid unless you file a valid claim.

When Will BeautyHealth Settlement Payments Be Sent?

No payment date has been announced. After the December 9 hearing, the administrator must process claims and apply the plan of allocation, and an appeal or objection could delay distribution. Check the settlement website for court orders and distribution updates.

BeautyHealth Settlement Timeline

Date	Event
May 10, 2022	Class period begins
August 9, 2023	BeautyHealth discloses refurbished-device margin pressure
November 13, 2023	Q3 results, $63.1 million restructuring charges, guidance cut; class period ends
November 16, 2023	Securities class action filed
June 17, 2026	Settlement agreement signed and disclosed by SkinHealth Systems in an SEC filing
October 6, 2026	Preliminary approval granted
November 24, 2026	Opt-out and objection deadline
December 9, 2026	Final approval hearing
January 19, 2027	Claim deadline

Frequently Asked Questions About the BeautyHealth $18 Million Settlement

Who qualifies for the BeautyHealth securities settlement?

Persons and entities that bought or acquired BeautyHealth common stock or call options, or sold or disposed of put options, from May 10, 2022 through November 13, 2023, inclusive, and were damaged, subject to the exclusions in the notice.

How much will BeautyHealth (SKIN) investors receive?

The estimated recovery is about $0.35 per allegedly damaged common share, but it is not guaranteed. Your payment depends on the plan of allocation and the total valid claims.

What is the BeautyHealth settlement claim deadline?

January 19, 2027.

What is the BeautyHealth settlement opt-out and objection deadline?

November 24, 2026. Requests must be received by that date, not merely postmarked.

When is the BeautyHealth settlement final approval hearing?

December 9, 2026, at 1:30 p.m. Pacific Time in Los Angeles.

Who pays the BeautyHealth settlement?

SkinHealth Systems contributes $3 million, and insurers cover the remaining $15 million.

Did SkinHealth Systems admit wrongdoing?

No. The company and the individual defendants deny wrongdoing and liability.

Do I need a lawyer to file a BeautyHealth settlement claim?

No. You can file yourself through the official website or by mail. Class counsel already represents the settlement class.

What if I no longer have my SKIN trade confirmations?

Ask your broker for historical account statements. Contact the administrator, Stretto, about whether other documentation is acceptable.

Where can I get the BeautyHealth claim form and notice?

At BeautyHealthSecuritiesLitigation.com, or by email at [email protected]. Use only the official website, since unofficial sites may charge fees or collect personal data.

Bottom Line

The BeautyHealth securities settlement offers $18 million to investors who bought SKIN stock or call options, or sold put options, between May 10, 2022 and November 13, 2023. The estimated recovery of about $0.35 per damaged common share is only an estimate. If you think you qualify, gather your brokerage records and file a valid claim by January 19, 2027. If you want to opt out or object, the deadline is November 24, 2026. The settlement still needs final court approval on December 9, 2026.

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the Summary Notice issued by lead counsel Hagens Berman, SkinHealth Systems Inc.’s June 2026 SEC disclosure and the Hagens Berman case page, as of October 27, 2026. Last Updated: October 27, 2026.

For informational purposes only; not legal or investment advice. AllAboutLawyer.com is a legal information website, not a law firm. The settlement remains subject to final court approval.

Sources: Official settlement website · Hagens Berman case page · SkinHealth Systems Form 8-K, June 17, 2026 · Bloomberg Law · 15 U.S.C. § 78j · 17 C.F.R. § 240.10b-5 · 15 U.S.C. § 78t